V.A. Cooperative study of antiplatelet agents in diabetic patients after amputation for gangrene: Unobserved, sudden, and unexpected deaths

Colwell, 1984, V.A. Cooperative Study on Antiplatelet Agents in Diabetic Patients After Amputation for Gangrene: I. Design, Methods, and Baseline Characteristics, Controlled Clinical Trials, 5, 165, 10.1016/0197-2456(84)90122-3 Colwell, 1986, V.A. Cooperative Study on Antiplatelet Agents in Diabetic Patients After Amputation for Gangrene: II. Effects of aspirin and dipyridamole on atherosclerotic vascular disease rates, Diabetes Care, 9, 140, 10.2337/diacare.9.2.140 Colwell, 1985, V.A. Cooperative Study on Antiplatelet Agents in Diabetic Patients After Amputation for Gangrene: III. Definitions and review of design and baseline characteristics, Horm Metab Res [Suppl], 15, 69 1980, Persantin-Aspirin Reinfarction Study: Design, methods and baseline results, Circulation, 63, II-1 Friedman, 1973, Instantaneous and sudden deaths. Clinical and pathological differentiation in coronary artery disease, JAMA, 225, 1319, 10.1001/jama.1973.03220390021005 El-Maraghi, 1980, The relevance of platelet and fibrin thromboembolism of the coronary microcirculation, with special reference to sudden cardiac death, Circulation, 62, 936, 10.1161/01.CIR.62.5.936 1982, Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results, JAMA, 248, 1465, 10.1001/jama.1982.03330120023025 Talbott, 1983, The epidemiology of sudden coronary death, J SC Med Assoc, 574 Talbott, 1977, Biologic and psychosocial risk factors of sudden death from coronary disease in white women, Am J Cardiol, 39, 858, 10.1016/S0002-9149(77)80040-4 Baroldi, 1979, Sudden coronary death. A post-mortem study in 208 selected cases compared to 97 “control” subjects, Am Heart J, 98, 20, 10.1016/0002-8703(79)90316-8 Roberts, 1979, Quantitation of coronary arterial narrowing at necropsy in sudden coronary death. Analysis of 31 patients and comparison with 25 control subjects, Am J Cardiol, 44, 39, 10.1016/0002-9149(79)90248-0 Davies, 1984, Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death, N Engl J Med, 310, 1137, 10.1056/NEJM198405033101801 Haerem, 1974, Mural platelet microthrombi and major acute lesions of main epicardial arteries in sudden coronary death, Atheroscierosis, 19, 529, 10.1016/S0021-9150(74)80017-1 Kannel, 1975, Precursors of sudden coronary death. Factors related to the incidence of sudden death, Circulation, 51, 606, 10.1161/01.CIR.51.4.606 Davis, 1980, The very sudden cardiac death syndrom—A conceptual model for pathologists, Human Pathol, 11, 117, 10.1016/S0046-8177(80)80128-6 Kannel, 1985, Sudden death: Update from Framingham, Continuing Education, 493 Garcia MJ, McNamara PM, Gordon T, Kannel WB: Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 23:105–111. 1970, A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes: II. Mortality results, Diabetes, 19, 789 1971, Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes: IV. A preliminary report on phenformin results, JAMA, 217, 777, 10.1001/jama.1971.03190060017005 O'Sullivan, 1973, Critique of the UGDP mortality analyses, 509 1974, Report of the Committee for the Assessment of Biometric Aspects of Controlled Trials of Hypoglycemic Agents, JAMA, 231, 583 Elwood, 1974, A randomized controlled trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction, Br Med J, 1, 436, 10.1136/bmj.1.5905.436 1976, Aspirin in coronary heart disease, J Chronic Dis, 29, 625, 10.1016/0021-9681(76)90020-5 1980, Randomized, controlled trial of aspirin in persons recovered from myocardial infarction, JAMA, 243, 661, 10.1001/jama.1980.03300330019023 1980, Persantine and aspirin in coronary heart disease, Circulation, 62, 449, 10.1161/01.CIR.62.3.449 Klimt, 1986, Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin, JACC, 7, 251, 10.1016/S0735-1097(86)80489-2 Bousser, 1983, “AICLA” Controlled Trial of Aspirin and Dipyridamole in the Secondary Prevention of Athero-Thrombotic Cerebral Ischemia, Stroke, 14, 5, 10.1161/01.STR.14.1.5 1989, Final report on the aspirin component of the ongoing Physicians' Health Study, N Engl J Med, 321, 129, 10.1056/NEJM198907203210301 Peto, 1988, Randomised trial of prophylactic daily aspirin in British male doctors, Br Med J, 296, 313, 10.1136/bmj.296.6618.313 Ewing, 1980, Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications, Ann Intern Med, 92, 308, 10.7326/0003-4819-92-2-308 Clarke, 1979, Diabetic autonomic neuropathy, Diabetologia, 17, 195, 10.1007/BF01235856 VanderZwaag, 1983, A cohort study of mortality in two clinic populations of patients with diabetes mellitus, Diabetes Care, 6, 341, 10.2337/diacare.6.4.341 Knabb, 1984, Effects of dipyridamole on myocardial adenosine and active hyperemia, Am J Physiol, 247, H804 Keltz, 1987, Dipyridamole-induced myocardial ischemia, JAMA, 257, 1515, 10.1001/jama.1987.03390110091034 1988, Secondary prevention of vascular disease by prolonged antiplatelet treatment, Br Med J, 296, 320, 10.1136/bmj.296.6618.320